ResearcherVirginia Polytechnic Inst And St UnivActive in the last 2 years
Irving C Allen
Matched on ORCID iD 0000-0001-9573-5250; OpenAlex author ID A5008179003; NIH RePORTER profile ID 9377796. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 6)
- Trials
- 0
- Grants
- 3
- Labs led
- 2
- Collaborators
- 5
2020: 1 grant · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 grants
Papers 6
- Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model. Last author DOI 10.3389/fimmu.2024.1352821↗
- NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. Last author DOI 10.3389/fonc.2023.1155831↗
- Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological Therapies. Last author DOI 10.1007/978-1-0716-1811-0_47↗
- Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.853779↗
- Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Last author DOI 10.1038/s41598-021-87228-5↗
- Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer. Last author DOI 10.1109/tuffc.2021.3078094↗
Grants 3
- Deploying Histotripsy Based Tumor Ablation Strategies to Treat Pancreatic Cancer R01CA269811↗
- Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications R01CA274439↗
- Employing Novel Porcine Models of Orthotopic Pancreatic Cancer to Evaluate Histotripsy Based Tumor Ablation Strategies R21EB028429↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Margaret A. Nagai-Singer · 4 shared papers, 2021–2023 · strength 0.68
- Paper NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. DOI 10.3389/fonc.2023.1155831↗
- Paper Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological Therapies. DOI 10.1007/978-1-0716-1811-0_47↗
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Alissa Hendricks-Wenger · 4 shared papers, 2021–2024 · strength 0.59
- Paper Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological Therapies. DOI 10.1007/978-1-0716-1811-0_47↗
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Rafael V. Davalos · 4 shared papers, 2021–2024 · strength 0.59
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Khan Mohammad Imran · 3 shared papers, 2022–2024 · strength 0.57
- Paper NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells. DOI 10.3389/fonc.2023.1155831↗
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Natalie Beitel-White · 3 shared papers, 2021–2024 · strength 0.41
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Paper Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarc… DOI 10.1038/s41598-021-87228-5↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.